Literature DB >> 3373706

Pancytopenia following low-dose oral methotrexate therapy for psoriasis.

J L Shupack1, G F Webster.   

Abstract

Low-dose oral methotrexate therapy was associated with the onset of anemia, leukopenia, and thrombocytopenia in two patients with psoriasis. Both patients survived, but required prolonged hospitalization. No precipitating factor other than methotrexate could be identified.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373706

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  4 in total

1.  Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.

Authors:  H Franck; R Rau; G Herborn
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

Review 2.  The practical use of methotrexate in psoriasis.

Authors:  J P Tung; H I Maibach
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

3.  Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.

Authors:  H Franck; R Rau; G Herborn
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

4.  Expansion of immature, nucleated red blood cells by transient low-dose methotrexate immune tolerance induction in mice.

Authors:  J Q Tran; D Grover; M Zhang; M Stapels; R Brennan; D S Bangari; P A Piepenhagen; E Roberts; P Oliva; F Zubair; J L Vela; S M Richards; A M Joseph
Journal:  Clin Exp Immunol       Date:  2020-12-16       Impact factor: 5.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.